ATARA BIOTHERAPEUTICS, INC. Earnings Per Share (Basic)
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Earnings Per Share (Basic) of -$0.32 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- ATARA BIOTHERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.32, a 260.00% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.29, a 108.22% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.25.
- ATARA BIOTHERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.32.
- ATARA BIOTHERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was $2.61.
- ATARA BIOTHERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$11.41.
- ATARA BIOTHERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$65.19.
- ATARA BIOTHERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$2.24.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.32 10-Q · filed 2026-08-12 | -$0.62 10-Q · filed 2026-08-12 | -$0.87 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.19 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2026-03-31 | -$0.29 10-Q · filed 2026-05-12 | -$0.55 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.86 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.71 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2025-12-31 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-08-12 | $2.61 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | -$0.32 10-Q · filed 2025-11-12 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-08-12 | $2.96 10-Q · filed 2025-11-12 | $1.98 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2025-06-30 | $0.20 10-Q · filed 2026-08-12 | $3.52 10-Q · filed 2026-08-12 | $2.47 derived: net income ÷ weighted average shares · filed 2026-08-12 | $0.56 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2025-03-31 | $3.53 10-Q · filed 2026-05-12 | $2.36 derived: net income ÷ weighted average shares · filed 2026-08-12 | $0.35 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.78 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2024-12-31 | -$1.19 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$3.81 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$6.62 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$11.41 10-K · filed 2026-03-16 | ||||
| 2024-09-30 | -$2.93 10-Q · filed 2025-11-12 | -$6.02 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$11.34 10-Q · filed 2025-11-12 | -$22.61 derived: net income ÷ weighted average shares · filed 2026-04-24 | ||||
| 2024-06-30 | -$3.10 10-Q · filed 2025-08-11 | -$8.64 10-Q · filed 2025-08-11 | -$20.74 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$35.60 derived: net income ÷ weighted average shares · filed 2026-04-24 | ||||
| 2024-03-31 | -$5.65 10-Q · filed 2025-05-15 | -$0.23 10-Q · filed 2024-05-09 | -$18.54 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$34.22 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$50.66 derived: net income ÷ weighted average shares · filed 2026-04-24 | |||
| 2023-12-31 | -$13.98 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$30.36 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$47.26 derived: net income ÷ weighted average shares · filed 2026-04-24 | -$65.19 10-K · filed 2025-03-07 | -$2.61 10-K · filed 2024-03-28 | |||
| 2023-09-30 | -$16.40 10-Q · filed 2024-11-12 | -$0.66 10-Q · filed 2023-11-01 | -$33.31 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$51.27 10-Q · filed 2024-11-12 | -$2.05 10-Q · filed 2023-11-01 | -$5.38 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||
| 2023-06-30 | -$16.91 10-Q · filed 2024-08-12 | -$0.68 10-Q · filed 2023-08-08 | -$34.89 10-Q · filed 2024-08-12 | -$1.40 10-Q · filed 2023-08-08 | -$3.13 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$3.88 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||
| 2023-03-31 | -$0.72 10-Q · filed 2024-05-09 | -$1.44 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$2.26 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$2.09 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||||
| 2022-12-31 | -$0.72 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$1.54 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$1.37 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$2.24 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | -$0.82 10-Q · filed 2023-11-01 | -$0.64 derived: net income ÷ weighted average shares · filed 2023-11-01 | -$1.51 10-Q · filed 2023-11-01 | -$2.46 derived: net income ÷ weighted average shares · filed 2023-11-01 | ||||
| 2022-06-30 | $0.18 10-Q · filed 2023-08-08 | -$0.69 10-Q · filed 2023-08-08 | -$1.63 derived: net income ÷ weighted average shares · filed 2023-11-01 | -$2.52 derived: net income ÷ weighted average shares · filed 2023-11-01 | ||||
| 2022-03-31 | -$0.87 10-Q · filed 2023-05-08 | -$1.83 derived: net income ÷ weighted average shares · filed 2023-11-01 | -$2.74 derived: net income ÷ weighted average shares · filed 2023-11-01 | -$3.65 derived: net income ÷ weighted average shares · filed 2023-11-01 | ||||
| 2021-12-31 | -$0.96 derived: net income ÷ weighted average shares · filed 2023-02-08 | -$1.86 derived: net income ÷ weighted average shares · filed 2023-02-08 | -$2.77 derived: net income ÷ weighted average shares · filed 2023-02-08 | -$3.63 10-K · filed 2023-02-08 | ||||
| 2021-09-30 | -$0.90 10-Q · filed 2022-11-08 | -$1.81 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$2.67 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | -$0.91 10-Q · filed 2022-08-08 | -$1.77 10-Q · filed 2022-08-08 | ||||||
| 2020-12-31 | -$4.15 10-K · filed 2023-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |